期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

CCK受体拮抗剂对吗啡戒断大鼠海马神经元CaMKⅡα mRNA及蛋白表达的影响 被引量：2

Effect of CCK receptor antagonists on CaMKⅡα mRNA and protein of neuron in hippocampus of morphine withdrawal rats
在线阅读 下载PDF
导出
摘要 目的研究胆囊收缩素(CCK)受体拮抗剂对吗啡戒断大鼠海马神经元CaMKⅡαmRNA及蛋白表达的影响,进一步探讨CCK受体拮抗剂抑制吗啡戒断症状的作用机制。方法应用剂量递增法皮下注射盐酸吗啡,建立大鼠吗啡躯体依赖模型,将模型鼠的海马组织制成细胞悬液,体外给予不同剂量CCK-A及CCK-B受体拮抗剂,采用RT-PCR和western blot技术分别检测海马神经元CaMKⅡα的mRNA及蛋白表达。结果①慢性吗啡成瘾大鼠海马神经元CaMKⅡα mRNA及蛋白表达与对照组相比均显著增高;②成瘾大鼠海马神经元细胞在给予纳洛酮催促戒断后,与对照组及吗啡组相比,CaMKⅡα mRNA及蛋白均显著降低;③纳洛酮催促戒断组加入不同剂量的CCK-A受体拮抗剂(CR-1409)、CCK-B受体拮抗剂(CR-2945),CaMKⅡα mRNA及蛋白表达与纳洛酮组相比显著升高,并随浓度的升高而升高,两种拮抗剂的作用以CR-2945起主要作用。结论CCK-A、CCK-B受体拮抗剂可以有效地抑制因纳洛酮催促戒断所引起的CaMKⅡα mRNA及蛋白表达降低,并具有剂量依赖性。 Objective To study the effect of CCK receptor antagonists on expressions of the Ca^2＋/ Calmodulin-Dependent Protein Kinase Ⅱ CaMK Ⅱα mRNA and protein of neuron in hippocampus of morphine withdrawal rats in order to explore mechanism of CCK receptor antagonists on inhibition morphine withdrawal symptom in rats. Methods The models of morphine physical dependent rats were established by subcutaneous injection of morphine in gradually increasing doses. Application of CCK-A and CCK-B receptor antagonists and naloxone in vitro after preparation cells suspension isolated from hippocampus of the models in chronic morphine administration rats. The expressions of Ca^2＋/Calmodulin-Dependent Protein Kinase Het mRNA and protein were assayed with methods of RT-PCR and western-blot. Results ①The expressions of the Ca^2＋/Calmodulin-Dependent KinaseⅡα mRNA and protein level of neuron in hippocampus of chronic morphine treatment rats were significantly increased as compared with the control group. ②Comparing with the control and morphine groups, application of naloxone to neuron in hippocampus of chronic morphine treatmented rats resulted in the decrease of CaMK pressions of Ca^2＋/Calmodulin-Dependent KinaseⅡα mRNA Ⅱ at both mRNA and protein levels. ③The exand protein level increased in a dose dependent manner by CCK-A receptor antagonists （CR-1409） and CCK-B receptor antagonists （ CR-2945 ）. CR-2945 had been shown to play an important role. Conclusion CCK-A and CCK-B receptor antagonists could enhanced the expressions of Ca^2＋/Calmodulin-dependent kinaseⅡα mRNA and protein which could be decreased by naloxone in a dose dependent manner.
作者 闫玉仙 倪志宇 丛斌 牛增强 余磊 赵丽 马春玲 张国忠 左敏
机构地区 河北医科大学法医系
出处 《中国法医学杂志》 CSCD 2007年第1期35-38,共4页 Chinese Journal of Forensic Medicine
关键词 法医毒理学 CCK受体拮抗剂 吗啡戒断 CaMKⅡα Forensic toxicology CCK receptor antagonists morphine withdrawal CaMK Ⅱα
分类号 D919 [医药卫生—法医学]
  • 相关文献

参考文献14

  • 1Kelley AE, Bakshi VP, Fleming S, et al. A pharmacological analysis of the substrates underlying conditioned feeding induced by repeated opioid stimulation of the nucleus accumbens[ J]. Neuropsychopharmacology, 2000, 23:455 -467.
  • 2Muller A, Koch B, Rene F, et al. Mechanisms of opioid tolerance and opioid dependence [ J]. Ann Fr Anesth Reanim, 2000, 19(3): 217-218.
  • 3Pommier B, Beslot F, Simon A, et al. Deletion of CCK2 receptor in mice results in an upregulation of the endogenous opioid system[J]. J Neurosic, 2002, 22(5): 2005 -2011.
  • 4Shippenberg TS, Koob G. Recent advances in animal models of drug addiction. In: Davis KL, Chamey D, Coyle JT, et al. Neuropsycho-pharmacology: the fifth generation of progrees[ R ]. Philadelphia: Lippincott Williams & Wilkins,2002:1382 - 1395.
  • 5梁建辉,叶向锋,郑继旺.钙调素与吗啡依赖[J].中国药物依赖性杂志,2001,10(1):10-12. 被引量：15
  • 6Takeuchi Y, Miyamoto E, Fukunaga K. Activation of the rat dopamine D2 receptor promoter by mitogen-activated protein kinase and Ca^2+/calmodulin-dependent protein kinase Ⅱ pathways[J]. J Neurochem, 2002, 83(4): 784-796.
  • 7Wang Y, Mishra R, Simonson MS. Ca^2+ /calmoduhn-dependent protein kinase Ⅱ stimulates c-los transcription and DNA synthesis by a Src-based mechanism in glomerular mesangial cells[J]. J Am Soc Nephrol, 2003, 14(1): 28-36.
  • 8Giese KP, Fedorov NB, Filipkowski RK, et al. Autophosphorylation at Thr286 of the a calcium-calmodulin kinase Ⅱ in LTP and learning[ J ]. Science, 1998,279: 870 - 873.
  • 9Liguang Lou, Tianhua Zhou, Ping Wang, et al. Modulation of Ca^2+/-dependent protein kinase Ⅱ activity byacute andc hronic morphine administration in rat hippocampus: differential regulation of αandβisoforms [ J ]. Mol Pharmacol,1999, 55(3): 557-563.
  • 10谷建平,丛斌,朱桂云,毕海涛,姚玉霞,李淑瑾.褪黑素对吗啡戒断大鼠脑内CaM和CaMKⅡ活性的影响[J].中国药物依赖性杂志,2004,13(4):269-271. 被引量：3

二级参考文献15

  • 1Lou LG,Zhou TH,Wang P,et al.Modulation of Ca2+/calmodulin-dependent protein kinase Ⅱ activity by acute and chronic morphine administration in rat hippocampus:differential regulation of α and β isoforms[J].Mol Pharmacol,1999,55(3):557-563
  • 2Hardeland R.New actions of melatonin and their relevance to biometeorology[J].Int J Biometeorol,1997,41(2):47-57
  • 3Pu L,Bao GB,Xu NJ,et al.Hippocampal long-term potentiation is reduced by chronic opiate treatment and can be restored by re-exposure to opiates[J].J Neurosci,2002,22(5):1914-1921
  • 4Pevet P,Bothorel B,Slotten H,et al.The chronobiotic properties of melatonin[ J].Cell Tissue Res,2002,309(1):183-191
  • 5Raghavendra V,Kulkarni SK.Possible mechanisms of action in melatonin reversal of morphine tolerance and dependence in mice[ J].Eur J Pharmacol,2000,409(3):279-289
  • 6Fan GH,Wang LE,Qiu HC,et al.Inhibition of calcium/calmodulin-dependent protein kinase Ⅱ in rat hippocampus attenuates morphine tolerance and dependence[ J].Mol Pharmacol,1999,56( 1):39-45
  • 7Hansen MR,Bok J,Devaiah AK,et al.Ca2+/calmodulin-dependent protein kinases Ⅱ and Ⅳ both promote survival but differ in their effects on axon growth in spiral ganglion neurons[J].J Neurosci Res,2003,72(2):169-184.
  • 8Soderling TR.Structure and regulation of calcium/calmodulin-dependent protein kinases Ⅱ and V [J].Biochim Biophys Acta,1996,1297(2):131-138.
  • 9Karl PG,Nikolai BF,Robert KF,et al.Autophosphorylation at Thr286 of the αcalcium-calmodulin kinase Ⅱ in LTP and learning[J].Science,1998,279(6):87-872.
  • 10Hinds HL,Ivan G,Kazu N,et al.Essential fimction of α-calcium/calmodulin-dependent protein kinase Ⅱ in neurotransmitter release at a glutamatergic central synapse[J].Neuroscience,2003,100(7):4275-4280.

共引文献15

同被引文献39

  • 1谷建平,丛斌,朱桂云,毕海涛,谷振勇,李淑瑾,杨明.褪黑素对吗啡戒断大鼠脑内cAMP和cGMP含量的影响[J].中国药物依赖性杂志,2005,14(1):24-26. 被引量：9
  • 2张璐,王保捷,丁梅.CCK受体基因多态性及与部分精神疾病症状的相关性[J].中国法医学杂志,2007,22(1):39-42. 被引量：3
  • 3王尔华.定量药物设计[M].北京:人民卫生出版社,1981:33-50.
  • 4Nieto MM,Wilson J,Cupo A,et al.Chronic morphine treatment modulates the extracellular levels of endogenous enkephalins in rat brain structures involved in opiate dependence:a microdialysis study[J].J Neurosci,2002,22:1034-1041.
  • 5Zhou Y,Sun YH,Zhang ZW,et al.Increased release of immuneoreactive cholecystokinin octapeptide by morphine and potentiation of μ-opioid analgesia by CCK-B receptor antagonist L-365,260 in rat spinal cord[J].Eur J Pharmacol,1993,234:147-154.
  • 6Mitchell JM,Bergren LJ.Cholecystokinin is necessary for the expression of morphine conditioned place preference[J].Pharmacol Biochem Behav,2006,85:787-795.
  • 7Huda A,Meng F,Devine DP,et al.Molecular and neuroanatomical properties of the endogenous opiate system:implications for treatment of opiate addiction[J].Semi Neurosci,1997,9:70-83.
  • 8Lu L,Huang MS,Liu ZY,et al.Cholecystokinin-B receptor antagonists attenuate morphine dependence and withdrawal in rats[J].Neuro Report,2000,11:829-832.
  • 9Wan SA.Cholecystokinin receptor[J].Am J physiol,1995,269:628-646.
  • 10José BL,Hélio Z.Involvement of dorsol-ateral periaqueductal gray cholecystokinin-2 receptors in the regulation of a panic-related behavior in rats[J].Brain Res,2005,1059:46-51.

引证文献2

二级引证文献3

中国法医学杂志
2007年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部